Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect.

Details for Australian Patent Application No. 2011222432 (hide)

Owner Alfa Wassermann S.p.A.

Inventors Viscomi, Giuseppe Claudio; Maffei, Paola; Lauro, Vittoria; Barbanti, Miriam; Confortini, Donatella; Braga, Dario

Agent Lord and Company

Pub. Number AU-A-2011222432

PCT Pub. Number WO2011/107970

Priority MI2010A000370 05.03.10 IT

Filing date 4 March 2011

Wipo publication date 9 September 2011

International Classifications

A61K 9/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/14 Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/28 Medicinal preparations characterised by special physical form - Dragees

A61K 31/437

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/107970 Priority application(s): WO2011/107970

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011222439-A process for the enzymatic synthesis of fatty acid alkyl esters

2011222431-Device for administering therapeutic agents vie endovascular infusion